Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT03651362

Completed

Linking Optic Nerve MRI and the Retinal Axonal Loss After Optic Neuritis (IRMANO)

Optic Neuritis
NCT01892722

Active, not recruiting

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

Multiple Sclerosis
NCT04782466

Active, not recruiting

ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program

Pediatric Multiple Sclerosis
NCT05605782

Active, not recruiting

A Post-Authorization, Long-term Study of Ozanimod Real-world Safety (ORION)

Multiple Sclerosis, Relapsing-Remitting
NCT05930821

Active, not recruiting

Exercise Training, Cognition, and Mobility in Older Adults With Multiple Sclerosis

Multiple Sclerosis | Cognitive Impairment | Older Adults | Walking Impairment
NCT04629274

Completed

In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO

Neuromyelitis Optica
NCT05304520

Completed

A Study for Tysabri Participant Preference

Relapsing-Remitting Multiple Sclerosis (RRMS)
NCT04860947

Active, not recruiting

Assessment of NfL and GFAP Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS Patients (NFL OCT)

Multiple Sclerosis
NCT02865018

Completed

Neuromyelitis Optica (NMO) & Cetirizine

Neuromyelitis Optica
NCT03423121

Completed

A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis

Progressive Multiple Sclerosis
NCT05587023

Active, not recruiting

Effect of Ultrasound-guided Left Stellate Ganglion Block on Rapid Recovery of Patients Undergoing Cardiac Valve Replacement and Its Mechanism

Possible Molecular Mechanism of Left Stellate Ganglion Block | Left Stellate Ganglion Block Can Quickly Restore the Left Stellate Ganglion
NCT04595045

Completed

Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis

Multiple Sclerosis
NCT02977533

Completed

A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis

Progressive Multiple Sclerosis
NCT02284568

Completed

A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo (ARPEGGIO)

Primary Progressive Multiple Sclerosis
NCT03980145

Completed

G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis

Progressive Multiple Sclerosis
NCT00988052

Terminated

A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course

Relapsing Multiple Sclerosis
NCT01047319

Terminated

A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis

Relapsing Multiple Sclerosis
NCT05031143

Completed

Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment

Vogt Koyanagi Harada Disease
NCT03302806

Completed

Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis (BIOSEP)

Progressive Multiple Sclerosis
NCT02913157

Completed

Hydroxychloroquine in Primary Progressive Multiple Sclerosis

Multiple Sclerosis, Primary Progressive
NCT01854359

Completed

Idebenone for Primary Progressive Multiple Sclerosis

Multiple Sclerosis | Primary Progressive Multiple Sclerosis
NCT02583594

Completed

A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis (SCALA)

Progressive Multiple Sclerosis
NCT02403570

Completed

Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis (ROMUS)

Multiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting
NCT02695394

Completed

Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS)
NCT04157283

Unknown

Sexual Dysfunction in Patients With Relapsing Remitting Multiple Sclerosis and Associated Comorbidities

Multiple Sclerosis | Sexual Dysfunction
NCT03749096

Withdrawn

Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome

Stiff-Person Syndrome
NCT03829826

Unknown

Efficacy and Mechanism of Action of SCIg in Patients With Stiff Person Syndrome (SPS)

Stiff-Person Syndrome
NCT02611401

Completed

Efficacy of MBI for Depressive Symptoms in Patients With MS

Depression | Multiple Sclerosis
NCT02398461

Completed

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Multiple Sclerosis, Acute Relapsing
NCT01815632

Unknown

Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) (ACTiMuS)

Progressive Multiple Sclerosis
NCT01943526

Completed

Ireland Natalizumab (TYSABRI) Observational Program (iTOP)

Relapsing-Remitting Multiple Sclerosis
NCT01339455

Terminated

Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica (SCT-NMO)

Neuromyelitis Optica
NCT03476915

Completed

Developmental Hip Dysplasia by Ultrasonographic Screening of Asymptomatic Infants at Assiut University Hospital

Orthopedic Disorder
NCT01085318

Completed

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

Multiple Sclerosis
NCT02665221

Terminated

Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY

Multiple Sclerosis
NCT00030940

Completed

Cause, Development, and Progression of Stiff-Person Syndrome

Stiff-Person Syndrome
NCT03147105

Unknown

Armergometry to Improve Mobility in MS (AMBOS)

Multiple Sclerosis
NCT02220933

Unknown

Effect of MD1003 in Spinal Progressive Multiple Sclerosis (MS-SPI)

Multiple Sclerosis
NCT01939002

Completed

Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017) (ALLOW)

Relapsing Multiple Sclerosis
NCT02308670

Completed

Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis
NCT02863484

Unknown

Cavernous Sinus Dissection and Bleeding in Meningiomas (OCS)

Meningiomas of the Middle Cranial Fossa
NCT02559765

Completed

Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.

Progressive Multiple Sclerosis
NCT02282826

Completed

A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis

Progressive Multiple Sclerosis
NCT00772525

Completed

Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis

Multiple Sclerosis | Neuritis | Optic Nerve
NCT01137201

Completed

Internal Hernia After Laparoscopic Gastric Bypass

The Prevalence of Surgery for Small Bowel Obstruction After LGBP Procedure.
NCT02310048

Completed

Comparative Oral Bioavailability Study of MT-1303

Relapsing-remitting Multiple Sclerosis
NCT02293967

Completed

Mass Balance Study of MT-1303

Relapsing-remitting Multiple Sclerosis
NCT02193217

Completed

A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303

Relapsing-remitting Multiple Sclerosis
NCT01759602

Completed

C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation

Neuromyelitis Optica
NCT00906737

Completed

Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities

Multiple Sclerosis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations